A new imaging collaboration between researchers at the Walter and Eliza Hall Institute’s Center for Dynamic Imaging in Australia has revealed cancer cell findings that may help predict how cells respond to chemotherapy and our overall understanding of the disease, according to a release from the Institute.

"Several studies have shown that the size of different organs is an important factor in cancer development. For example, women with larger breasts have a greater risk of breast cancer. We wanted to check if this was also the case for brain tumors," said lead author of a new study, Even Hovig Fyllingen, in a prepared statement.

Two new studies demonstrate further evidence that a new noninvasive imaging technique can detect early Alzheimer’s Disease (AD) in seconds, according to research presented at the American Academy of Ophthalmology’s annual meeting in Chicago.

A score made up of four MRI markers of cerebral small vessel disease (CSVD) has been linked to stroke, dementia and mortality in older adults, reported authors of an Oct. 24 study published in Stroke.

A new study published in Experimental and Therapeutic Medicine found combining a CT scan with pathology results would improve the diagnosis and differential diagnosis of lung ground-glass opacity (GGO).

Elderly patients with vascular brain injury (VBI) who carry MRI markers—including white matter hyperintensities of presumed vascular origin, MRI–defined covert brain infarcts, cerebral microbleeds and perivascular spaces—have an increased risk of stroke, dementia and death, according to new research published Oct. 22 in JAMA Neurology.

Stereotactic body radiation therapy (SBRT) is both safe and effective for men with low- and intermediate-risk prostate cancer, according to research presented Oct. 22 at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting.

Women with early-stage breast cancer who receive large doses of radiation once a week for five weeks will experience the same long-term side effects as women who undergo conventional radiation therapy, according to a ten-year study presented Oct. 21 at the 2018 American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas.